MedTrace Logo

Testing Design Thinking Methodology to Engage Hispanic and Latino Families of Autistic Children in Research.

NCT06111092 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 186

Last updated 2023-11-02

No results posted yet for this study

Summary

The goal of this study is to compare the level of engagement in the Hispanic and Latino parents of autistic children and culturally adapt the protocol of Ayres Sensory Integration to improve participation and health outcomes.

The main questions it aims to answer are:

Does the Design Thinking process result in higher stakeholder engagement and satisfaction in the research process in comparison to Focus Groups? Secondary question: Do cultural adaption using DT data yield higher scores of acceptability and implementation feasibility in comparison to FG methods?

Participants will:

* Be randomized into two groups of engagement (focus groups and design thinking)
* Be blinded (clinicians, selected caregivers, autistic persons, and cultural experts) and will rate the acceptability, feasibility, and cultural appropriateness of the protocol based on DT data higher than the protocol based on FG data.

Conditions

Interventions

OTHER

Design Thinking

Participants attend the DT session through all the stages that include emphasize, define, ideate, prototype and test.

OTHER

Focus Groups

Participants attend the FG that includes the introduction. discussion, and reflection.

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Roseann C Schaaf · Thomas Jefferson University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2026-07-31
Completion
2026-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06111092 on ClinicalTrials.gov